A Prospective Evaluation of the Diagnostic Utility for Low‐Coverage Genome Sequencing in Prenatal Samples: A Comparison With Chromosomal Microarray Analysis
Prenatal Diagnosis · 2025
DOI: 10.1002/pd.6840 ↗Kurz gefasst
Vergleichsstudie in der Zeitschrift Prenatal Diagnosis, 2025. Verfasst von Yan Yin und 11 weiteren Autor:innen. Beteiligte Einrichtung: The Center of Prenatal Diagnosis, Sichuan Provincial Women's and Children's Hospital/The Affiliated Women's and Children's Hospital of Chengdu Medica…. Hauptthemen laut MEDLINE: Prenatal Diagnosis, Whole Genome Sequencing, Microarray Analysis, Chromosome Disorders. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 23 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: Development and Regeneration Key Laboratory of Sichuan Province, Medical Research Project of the Chengdu Health Commission.
Abstract (Originalsprache)
Objective
The present study aimed to evaluate the efficacy of LC‐GS in detecting clinically relevant chromosomal abnormalities in comparison with conventional CMA within a prenatal context.
Methods
We conducted a prospective study involving 200 amniotic fluid samples. All specimens were analyzed via LC‐GS and traditional tests, including CMA and karyotyping. LC‐GS was performed with 3X coverage to gauge its proficiency in identifying copy number variations (CNVs), aneuploidies, regions of homozygosity (ROH), and chromosome mosaicism. Data from both methods were compared to evaluate their sensitivity, specificity, and overall clinical utility.
Results
LC‐GS at a depth of 3X identified a total of 77 positive samples, yielding a detection rate of 38.5% (77/200). This included 17 cases of aneuploidy, 36 instances of CNVs, 20 cases linked to ROH, and 8 cases of chromosomal mosaicism. LC‐GS demonstrated high concordance with CMA in aneuploidy, CNVs, ROH, and chromosomal mosaicism, achieving a diagnostic yield of 21% (42/200), with additional benefits of reduced cost. Moreover, LC‐GS outperformed CMA in terms of resolution for identifying submicroscopic CNVs.
Conclusion
LC‐GS presents a robust alternative to CMA for prenatal diagnosis, effectively identifying aneuploidies, CNVs, chromosomal mosaicism, and ROH. It delivers comparable sensitivity and specificity in the detection of a wide spectrum of genomic abnormalities.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Autor:innen und Institutionen
- The Center of Prenatal Diagnosis, Sichuan Provincial Women's and Children's Hospital/The Affiliated Women's and Children's Hospital of Chengdu Medical College, Chengdu, China.
- The Department of Obstetric and Gynecologic, Sichuan Provincial Women's and Children's Hospital/The Affiliated Women's and Children's Hospital of Chengdu Medical College, Chengdu, China.
- Becreative Lab Co. Ltd, Beijing, China.
- Zhejiang Biosan Biochemical Technologies Co. Ltd, Hangzhou, China.
ORCID-Profile: Yan Yin, Shengfang Qin, Xueyan Wang
Förderung
- Development and Regeneration Key Laboratory of Sichuan Province
- Medical Research Project of the Chengdu Health Commission
Zitieren
APA
Yin, Y., He, Y., Chen, C., He, Y., Wang, J., Qin, S., Wang, H., Ma, K., Hu, D., Xiao, R., Wang, G., & Wang, X. (2025). A Prospective Evaluation of the Diagnostic Utility for Low‐Coverage Genome Sequencing in Prenatal Samples: A Comparison With Chromosomal Microarray Analysis. Prenatal Diagnosis. https://doi.org/10.1002/pd.6840
Vancouver
Yin Y, He Y, Chen C, He Y, Wang J, Qin S, et al. A Prospective Evaluation of the Diagnostic Utility for Low‐Coverage Genome Sequencing in Prenatal Samples: A Comparison With Chromosomal Microarray Analysis. Prenatal Diagnosis. 2025. doi:10.1002/pd.6840
BibTeX
@article{Yin2025,
author = {Yin, Yan and He, Yuxia and Chen, Chun and He, Yanyan and Wang, Jin and Qin, Shengfang and Wang, Hongna and Ma, Kun and Hu, Dahui and Xiao, Rui and Wang, Gang and Wang, Xueyan},
title = {A Prospective Evaluation of the Diagnostic Utility for Low‐Coverage Genome Sequencing in Prenatal Samples: A Comparison With Chromosomal Microarray Analysis},
journal = {Prenatal Diagnosis},
year = {2025},
doi = {10.1002/pd.6840}
}
EUVIMED